Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

204 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
Hensing TA, Schell MJ, Lee JH, Socinski MA. Hensing TA, et al. Among authors: schell mj. Lung Cancer. 2005 Feb;47(2):253-9. doi: 10.1016/j.lungcan.2004.07.040. Lung Cancer. 2005. PMID: 15639724 Clinical Trial.
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.
Socinski MA, Neubauer MA, Olivares J, Ketchel S, Tynan M, Moore M, Lee JH, Davis K, Schell M, Garfield D. Socinski MA, et al. Among authors: schell m. Lung Cancer. 2003 Apr;40(1):91-7. doi: 10.1016/s0169-5002(02)00527-5. Lung Cancer. 2003. PMID: 12660013 Clinical Trial.
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone.
Lindley C, Goodin S, McCune J, Kane M, Amamoo MA, Shord S, Pham T, Yowell S, Laliberte K, Schell M, Bernard S, Socinski MA. Lindley C, et al. Among authors: schell m. Am J Clin Oncol. 2005 Jun;28(3):270-6. doi: 10.1097/01.coc.0000145983.35929.2a. Am J Clin Oncol. 2005. PMID: 15923800 Clinical Trial.
Cholelithiasis after treatment for childhood cancer.
Mahmoud H, Schell M, Pui CH. Mahmoud H, et al. Among authors: schell m. Cancer. 1991 Mar 1;67(5):1439-42. doi: 10.1002/1097-0142(19910301)67:5<1439::aid-cncr2820670529>;2-r. Cancer. 1991. PMID: 1899356
Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation.
Osann KE, Lowery JT, Schell MJ. Osann KE, et al. Among authors: schell mj. Lung Cancer. 2000 Apr;28(1):1-10. doi: 10.1016/s0169-5002(99)00106-3. Lung Cancer. 2000. PMID: 10704703
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.
Haura EB, Tanvetyanon T, Chiappori A, Williams C, Simon G, Antonia S, Gray J, Litschauer S, Tetteh L, Neuger A, Song L, Rawal B, Schell MJ, Bepler G. Haura EB, et al. Among authors: schell mj. J Clin Oncol. 2010 Mar 10;28(8):1387-94. doi: 10.1200/JCO.2009.25.4029. Epub 2010 Feb 8. J Clin Oncol. 2010. PMID: 20142592 Free PMC article. Clinical Trial.
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.
Gray JE, Haura E, Chiappori A, Tanvetyanon T, Williams CC, Pinder-Schenck M, Kish JA, Kreahling J, Lush R, Neuger A, Tetteh L, Akar A, Zhao X, Schell MJ, Bepler G, Altiok S. Gray JE, et al. Among authors: schell mj. Clin Cancer Res. 2014 Mar 15;20(6):1644-55. doi: 10.1158/1078-0432.CCR-13-2235. Epub 2014 Jan 15. Clin Cancer Res. 2014. PMID: 24429877 Free PMC article. Clinical Trial.
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers.
Gray JE, Altiok S, Alexandrow MG, Walsh FW, Chen J, Schell MJ, Tai DF, Bepler G. Gray JE, et al. Among authors: schell mj. Cancer. 2013 Mar 1;119(5):1023-32. doi: 10.1002/cncr.27836. Epub 2012 Oct 12. Cancer. 2013. PMID: 23065656 Free PMC article. Clinical Trial.
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.
Mahmood ST, Agresta S, Vigil CE, Zhao X, Han G, D'Amato G, Calitri CE, Dean M, Garrett C, Schell MJ, Antonia S, Chiappori A. Mahmood ST, et al. Among authors: schell mj. Int J Cancer. 2011 Oct 15;129(8):1963-9. doi: 10.1002/ijc.25843. Epub 2011 Mar 25. Int J Cancer. 2011. PMID: 21154746 Free PMC article. Clinical Trial.
Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells.
Gao J, Zheng Z, Rawal B, Schell MJ, Bepler G, Haura EB. Gao J, et al. Among authors: schell mj. Cancer Biol Ther. 2009 Sep;8(17):1671-9. doi: 10.4161/cbt.8.17.9322. Epub 2009 Sep 20. Cancer Biol Ther. 2009. PMID: 19633423 Free PMC article.
204 results
Jump to page